Press Room

SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases.

DOVER, DE – The Delaware State Senate has unanimously passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.

After months of debate, state lawmakers have finalized New York’s state budget, opting to preserve access to biomarker testing for Medicaid enrollees. The adopted budget changed language in the historic biomarker testing law, initially passed in 2023, to clarify biomarker testing is covered when it is medically necessary. The law will retain the most important criteria used for determining when testing is to be covered, drawing praise from cancer survivors and patient advocates.  

Cancer Advocates Applaud the State Legislature's Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care. 

Late Friday, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) released a final rule on the Patient Protection and Affordable Care Act HHS Notice of Benefit and Payment Parameters (NBPP) for plan year 2027.

Cancer Advocates Gathered at the Statehouse Today to Say Ohio Can and Must Do Better to Reduce the Burden of Cancer

Visual Elements Available for Download:

NASHVILLE, Tenn. – Gov.

RALEIGH, N.C. – Cancer advocates, patients, survivors and caregivers from around the state will gather at the General Assembly on Tuesday, May 12, to ask lawmakers to make cancer policy a priority for Cancer Action Day hosted by the American Cancer Society Cancer Action Network (

Illinois Must Do Better to Reduce the Burden of Cancer